Defining "innovativeness" in drug development: a systematic review.
about
Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient PharmaceuticalsBuilding a drug development database: challenges in reliable data availability.How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012Commentary: Comparison of historical medical spending patterns among the BRICS and G7Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006-2015: a cohort study.Measuring the efficiency of large pharmaceutical companies: an industry analysis.Determinants of new drugs prescription in the Swiss healthcare market.Molecular insights provide the critical path to disease mitigation.
P2860
Q28550319-E8EBE2AE-64AC-47C5-878B-945C1FEA4992Q31119778-0B0B7BA7-E4EC-4EA9-BD48-A6AB5B538C37Q34417204-AFC642F9-7762-47FF-8963-849BC0C0C9D9Q37092539-EA9D1081-6FFB-4865-85E9-C5585B396844Q38912868-DC8D836F-F1EA-4C35-A7BE-3BE8376D27D4Q39654944-506C4C0C-AFC2-47ED-8D81-FB73E55905FAQ47562781-3CFC58D2-89B1-49D1-A88C-5BF598603481Q48384103-95EDC317-6F2A-4D1B-977F-14A087A49507
P2860
Defining "innovativeness" in drug development: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Defining "innovativeness" in drug development: a systematic review.
@en
type
label
Defining "innovativeness" in drug development: a systematic review.
@en
prefLabel
Defining "innovativeness" in drug development: a systematic review.
@en
P2860
P356
P1476
Defining "innovativeness" in drug development: a systematic review
@en
P2860
P304
P356
10.1038/CLPT.2013.115
P407
P577
2013-05-30T00:00:00Z